至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles

Bioconjug Chem. 2014-01-01; 
Marwa M Afifi, Lauren A Austin, Megan A Mackey, Mostafa A El-Sayed
Products/Services Used Details Operation
Peptide Synthesis … 40 kcal mol –1 .(34). The RGD peptide is known to target α v β 6 surface integrins, expressed on HSC-3 cells, increasing nanoparticle uptake by the cancer cells.(35, 36) A custom RGD peptide (RGDRGDRGDRGDPGC) purchased from GenScript USA, Inc … Get A Quote

摘要

Nanoparticles as potential drug delivery vectors are drawing more attention every day. Here, we used gold nanopspheres (AuNSs) to selectively target the Wnt signaling pathway in human oral squamous cell carcinoma (HSC-3) cells. In a previously conducted study, XAV939, a small inhibiter, was found to strongly regulate the Wnt pathway by inhibiting the tankyrase enzyme and subsequent stabilization of cytoplasmic axin levels. In the present study, conjugating XAV939 molecules to AuNSs is found to enhance its potency by at least 100 times over its free form in killing HSC-3 cancer cells. Additionally, XAV 939 uptake studies have demonstrated an enhanced XAV939 bioconjugate delivery to the targeted cells compared to... More

关键词